Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regeneration's xenograft screw:

This article was originally published in Clinica

Executive Summary

Regeneration Technologies', Sterling, interference screw for use in an arthroscopic or open ACL and/or PCL reconstruction. It has a long-term absorption rate, which ensures secure graft fixation throughout the healing process, and a pullout strength that is comparable to metal interference screws, says the Alachua, Florida firm. The implant is treated with the company's patented BioCleanse tissue sterilisation process, which is designed to eliminate viruses, bacteria, fungi and spores from tissue without impacting its structural or biomechanical integrity. The screw is expected to become available for distribution in late 2005.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055660

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel